Reliability of the Beck Depression Inventory in opiate-dependent patients

References

• Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology, 56, 893–897
   PubMed Web of Science ®Google Scholar
• Charney, D. A., Paraherakis, A. M., & Gill, K. J. (2001). Integrated treatment of comorbid depression and substance use disorders. The Journal of Clinical Psychiatry, 62, 672–677
   PubMed Web of Science ®Google Scholar
• Darke, S., Mills, K., Teesson, M., Ross, J., Williamson, A., & Havard, A. (2009). Patterns of major depression and drug-related problems amongst heroin users across 36 months. Psychiatry Research, 166, 7–14
   PubMed Web of Science ®Google Scholar
• Dorus, W., & Senay, E. C. (1980). Depression, demographic dimensions, and drug abuse. The American Journal of Psychiatry, 137, 699–704
   PubMed Web of Science ®Google Scholar
• Dum, M., Pickren, J., Sobell, L. C., & Sobell, M. B. (2008). Comparing the BDI-II and the PHQ-9 with outpatient substance abusers. Addictive Behaviors, 33, 381–387
   PubMed Web of Science ®Google Scholar
• First, M., Spitzer, R., & Gibbon, M. W. J. (1997). Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). Washington, DC: American Psychiatric Press
   Google Scholar
• Gowing, L. R., Farrell, M., Bornemann, R., Sullivan, L. E., & Ali, R. L. (2006). Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection. Journal of General Internal Medicine, 21, 193–195
   PubMed Web of Science ®Google Scholar
• Hasin, D., Liu, X., Nunes, E., McCloud, S., Samet, S., & Endicott, J. (2002). Effects of major depression on remission and relapse of substance dependence. Archives of General Psychiatry, 59, 375–380
   PubMed Web of Science ®Google Scholar
• Hasin, D., Samet, S., Nunes, E., Meydan, J., Matseoane, K., & Waxman, R. (2006). Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. The American Journal of Psychiatry, 163, 689–696
   PubMed Web of Science ®Google Scholar
• Havard, A., Teesson, M., Darke, S., & Ross, J. (2006). Depression among heroin users: 12-Month outcomes from the Australian Treatment Outcome Study (ATOS). Journal of Substance Abuse Treatment, 30, 355–362
   PubMed Web of Science ®Google Scholar
• Hepner, K., Hunter, S., Edelen, M., Zhou, A., & Watkins, K. (2009). A comparison of two depressive symptomatology measures in residential substance abuse treatment clients. Journal of Substance Abuse Treatment, 37, 318–325
   PubMed Web of Science ®Google Scholar
• Hesse, M. (2006). The Beck Depression Inventory in patients undergoing opiate agonist maintenance treatment. British Journal of Clinical Psychology, 45, 417–425
   PubMed Web of Science ®Google Scholar
• Kelly, T. M., Daley, D. C., & Douaihy, A. B. (2012). Treatment of substance abusing patients with comorbid psychiatric disorders. Addictive Behaviors, 37, 11–24
   PubMed Web of Science ®Google Scholar
• Mills, K. L., Teesson, M., Darke, S., Ross, J., & Lynskey, M. (2004). Young people with heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS). Journal of Substance Abuse Treatment, 27, 67–73
   PubMed Web of Science ®Google Scholar
• Nunes, E. V., Donovan, S. J., Brady, R., & Quitkin, F. M. (1994). Evaluation and treatment of mood and anxiety disorders in opioid-dependent patients. Journal of Psychoactive Drugs, 26, 147–153
   PubMed Web of Science ®Google Scholar
• Peles, E., Schreiber, S., Naumovsky, Y., & Adelson, M. (2007). Depression in methadone maintenance treatment patients: Rate and risk factors. Journal of Affective Disorders, 99, 213–220
   PubMed Web of Science ®Google Scholar
• Pettinati, H. M., O’Brien, C. P., & Dundon, W. D. (2013). Current status of co-occurring mood and substance use disorders: A new therapeutic target. The American Journal of Psychiatry, 170, 23–30
   PubMed Web of Science ®Google Scholar
• Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA: The Journal of the American Medical Association, 264, 2511–2518
   PubMed Web of Science ®Google Scholar
• Roncero, C., Fuste, G., Barral, C., Rodríguez-Cintas, L., Martínez-Luna, N., Eiroa-Orosa, F. J., & Casas, M. (2011). Therapeutic management and comorbid psychiatric disorders among opiate dependent patients in replacement therapy programs: The PROTEUS study. Heroin Addict Relat Clin Probl, 13, 5–16
   Web of Science ®Google Scholar
• Rounsaville, B. J., Weissman, M. M., Rosenberger, P. H., Wilber, C. H., & Kleber, H. D. (1979). Detecting depressive disorders in drug abusers: A comparison of screening instruments. Journal of Affective Disorders, 1, 255–267
   PubMed Web of Science ®Google Scholar
• Sanabria, M., Díaz, O., & Varela, J. B. T. (2002). Relevancia para el tratamiento de la sintomatología depresiva de los pacientes adictos. Adicciones, 14, 25–32
   Google Scholar
• Seignourel, P. J., Green, C., & Schmitz, J. M. (2008). Factor structure and diagnostic efficiency of the BDI-II in treatment-seeking substance users. Drug and Alcohol Dependence, 93, 271–278
   PubMed Web of Science ®Google Scholar
• Smit, F., Ederveen, A., Cuijpers, P., Deeg, D., & Beekman, A. (2006). Opportunities for cost-effective prevention of late-life depression: An epidemiological approach. Archives of General Psychiatry, 63, 290–296
   PubMed Web of Science ®Google Scholar
• Steer, R. A., Iguchi, M. Y., & Platt J. (1992). Use of the revised Beck Depression Inventory with intravenous drug users not in treatment. Psychology of Addictive Behaviors, 6, 225–232
   Google Scholar
• Strain, E. C., Stitzer, M. L., & Bigelow, G. E. (1991). Early treatment time course of depressive symptoms in opiate addicts. The Journal of Nervous and Mental Disease, 179, 215–221
   PubMed Web of Science ®Google Scholar
• Torrens, M., Fonseca, F., Mateu, G., & Farré, M. (2005). Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis. Drug and Alcohol Dependence, 78, 1–22
   PubMed Web of Science ®Google Scholar
• Torrens, M., Martin-Santos, R., & Samet, S. (2006). Importance of clinical diagnoses for comorbidity studies in substance use disorders. Neurotoxicity Research, 10, 253–261
   PubMed Web of Science ®Google Scholar
• Torrens, M., Serrano, D., Astals, M., Pérez-Domínguez, G., & Martín-Santos, R. (2004). Diagnosing comorbid psychiatric disorders in substance abusers: Validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. The American Journal of Psychiatry, 161, 1231–1237
   PubMed Web of Science ®Google Scholar
• Vázquez, C., & Sanz, J. (1999). Reliability and validity of the Spanish version of Beck’s Depression Inventory (1978) in patients with psychological disorders. Clínica Y Salud, 10, 59–81
   Google Scholar
• Wang, P.-W., Wu, H.-C., Yen, C.-N., Yeh, Y.-C., Chung, K.-S., Chang, H.-C., & Yen, C.-F. (2012). Predictors of the severity of depressive symptoms among intravenous heroin users receiving methadone maintenance treatment in Taiwan: An 18-month follow-up study. Psychology of Addictive Behaviors: Journal of the Society of Psychologists in Addictive Behaviors, 26, 145–150
   PubMed Web of Science ®Google Scholar
• Williams, J. B., Gibbon, M., First, M. B., Spitzer, R. L., Davies, M., Borus, J., & Rounsaville, B. (1992). The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test–retest reliability. Archives of General Psychiatry, 49, 630–636
   PubMed Web of Science ®Google Scholar